Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
NOVO.B-DK
NOVO.B-DK News & Events
-
Add to Watchlist
Trade NOVO.B-DK
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
NOVO.B-DK News
Wall Street Anticipated a Surge of Deals Under Trump in 2025, But It Proved More Complicated
Dec 19 2025
CNBC
Eli Lilly reports that obesity medication aids in sustaining weight loss following patients' transition from Wegovy and Zepbound.
Dec 18 2025
CNBC
Eli Lilly's advanced obesity medication shows significant weight loss and alleviates knee pain in final trial phase.
Dec 11 2025
CNBC
Pfizer Expands Obesity Investment with $2.1 Billion Agreement to Develop Pill from Chinese Firm
Dec 09 2025
CNBC
Eli Lilly Reduces Prices, Thanksgiving Box Office Update, Challenges for Gravestone Manufacturers, and More in Morning Squawk
Dec 01 2025
CNBC
Eli Lilly reduces cash prices for Zepbound weight loss drug vials on its direct-to-consumer platform.
Dec 01 2025
CNBC
The Importance of Medicare Price Negotiations for Novo Nordisk, AstraZeneca, and Other European Pharmaceutical Firms
Nov 26 2025
CNBC
Novo Nordisk Faces Challenges from Eli Lilly in GLP-1 Drug Competition: Which Stock Should Investors Consider?
Nov 24 2025
CNBC
Show More News
NOVO.B-DK Events
No data
NOVO.B-DK Monitor News
No data
NOVO.B-DK Earnings Analysis
No Data
People Also Watch
